[1] Frost HM. The regional acceleratory phenomenon: a review[J]. Henry Ford Hosp Med J, 1983, 31(1): 3-9.
[2] 黄丹青, 康非吾, 周小康, 等. 下颌截骨术对兔颌骨非术区骨改建的影响[J]. 口腔颌面外科杂志, 2016, 26(2): 83-87.
[3] Caetano-Lopes J, Lopes A, Rodrigues A, et al. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing[J]. PloS one, 2011, 6(2):e16947.
[4] Petrovic-Rackov L. Cytokines in rheumatoid arthritis and osteoarthrosis[J]. Medicinski pregled, 2005, 58(5-6):245-251.
[5] Tatsuya Tamura, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin6[J]. P Natl Acard Sci USA, 1993, 90(24):11924-11928.
[6] Collin-Osdoby P, Osdoby P. RANKL-mediated osteoclast formation from murine RAW 264.7 cells[J]. Methods Mol Biol, 2012, 816:187-202.
[7] Nakashima T, Hayashi M, Fukunaga T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression[J]. Nature medicine, 2011, 17(10):1231-1234.
[8] Zhao S, Zhang YK, Harris S, et al. MLO-Y4 osteocyte-like cells support osteoclast formation and activation[J]. J Bone Miner, 2002, 17(11):2068-2079.
[9] O'Sullivan LA, Liongue C, Lewis RS, et al. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease[J]. Molecular immunology, 2007, 44(10):2497-2506.
[10] Choe JY, Park KY, Park SH, et al. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes[J]. Arthritis Res Ther, 2013, 15(1):R26.
[11] Li J. JAK-STAT and bone metabolism[J]. Jak-Stat, 2013, 2(3):e23930.
[12] Udagawa N, Takahashi N, Katagiri T, et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors[J]. J Exp Med, 1995, 182(5):1461-1468.
[13] Xiong J, Onal M, Jilka RL, et al. Matrix-embedded cells control osteoclast formation[J]. Nature Medicine, 2011, 17(10):1235-1241.
[14] O'Brien CA, Nakashima T, Takayanagi H. Osteocyte control of osteoclastogenesis[J]. Bone, 2013, 54(2):258-263.
[15] Jones SA, Rose-John S. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex[J]. Biochim Biophys Acta, 2002, 1592(3):251-263.
[16] Xiong J, Piemontese M, Thostenson JD, et al. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency[J]. Bone, 2014, 66(9):146-154.
[17] Kulkarni RN, Bakker AD, Everts V, et al. Mechanical loading prevents the stimulating effect of IL-1beta on osteocyte-modulated osteoclastogenesis[J]. Biochemical and biophysical research communications, 2012, 420(1):11-16. |